Comprehensive analysis of N6-methyladenosine (m6A) modification during the degeneration of lumbar intervertebral disc

Bin Zhu1, Hao-Xiang Chen1, Shan Li1

  • 1Department of Spine Surgery, The First Affiliated Hospital of University of South China, Hengyang, China.

Abstract

Insights

This study reveals the N6-methyladenosine (m6A) modification patterns in nucleus pulposus tissue during intervertebral disc degeneration (IDD) in mice. Findings highlight RNA methylation

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genomics

Background:

  • Intervertebral disc degeneration (IDD) is a major cause of low back pain, necessitating a deeper understanding of its molecular mechanisms.
  • N6-methyladenosine (m6A) RNA modification plays a crucial role in various biological processes, but its role in IDD remains largely unexplored.

Purpose of the Study:

  • To investigate the m6A modification patterns in nucleus pulposus (NP) tissue during the progression of intervertebral disc degeneration (IDD).
  • To identify key genes and pathways regulated by m6A methylation in the context of IDD.

Main Methods:

  • Generation of a standing mouse model to induce IDD.
  • Methylated RNA immunoprecipitation with next-generation sequencing (MeRIP-seq) to profile m6A-associated transcripts in NP tissue.
  • Quantitative real-time PCR (qRT-PCR) to assess the expression of methylation-related enzymes.

Main Results:

  • The mouse model successfully replicated IDD, with altered expression of m6A methylases and demethylases in degenerated NP tissue.
  • MeRIP-seq identified 985 differentially expressed genes and 1319 differentially methylated m6A peaks in IDD compared to control.
  • Enrichment analysis revealed specific genes and pathways implicated in the pathogenesis of IDD.

Conclusions:

  • This study elucidates the m6A methylation landscape in degenerated mouse NP tissue.
  • The findings provide novel insights into the role of RNA methylation in IDD and suggest potential therapeutic targets.